Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific Bsx Gains From Acquisitions, New Launches is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific’s $3.7B Axonics buy tops list of medtech M&A in 2024
Medtech dealmaking has not yet taken off this year, but there have been a number of smaller tuck-in acquisitions and private equity agreements. Read More
Boston Scientific (BSX) Grows IC Business With New FDA Nod
Boston Scientific Corporation BSX achieved a milestone with the recent ... driven by technological advancements and strategic acquisitions. This market is expected to reach $38.27 billion in ... Read More
Boston Scientific (NYSE: BSX)
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and ... Read More
Latest News for Boston Scientific Stock (NYSE:BSX)
Boston Scientific shares are trading higher after the company announced it initiated the AVANT GUARD clinical trial to evaluate the FARAPULSE Pulsed Field Ablation System as a first-line treatment ... Read More
Boston Scientific (BSX) Surges 4.6%: Will the Rally Continue?
Boston Scientific, Inc. BSX appears in good shape ... banking on successful expansion in its base led by a diverse portfolio, new launches and commercial execution with healthy underlying market ... Read More
Boston Scientific Corp BSX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ... Read More
Axonics ticks higher as Boston Scientific reiterates close in 1H24
Axonics (NASDAQ:AXNX) ticked up 0.2% after Boston Scientific (NYSE:BSX) earlier reiterated that it sees a first half close of this year for its planned $3.7 billion acquisition. Boston Scientific ... Read More
Piper Sandler Keeps Their Buy Rating on Boston Scientific (BSX)
Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Boston Scientific (BSX – Research Report) today and set a price target of $72.00. The company’s shares closed yesterday at ... Read More
Boston Scientific: FDA Approves AGENT Drug-Coated Balloon - Quick Facts
(RTTNews) - Boston Scientific Corporation (BSX) has received ... Boston Scientific plans to launch it in the U.S. in the coming months. For More Such Health News, visit rttnews.com. Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus